Graft Occlusion, Vascular
5
0
0
4
Key Insights
Highlights
Success Rate
80% trial completion
Treatment Research
5 treatments under study, led by Bo653
Research Leaders
5 sponsors active, led by University Hospital, Bordeaux
Related Conditions
Often studied with 10 related conditions
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
20.0%
1 terminated out of 5 trials
80.0%
-6.6% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (5)
GFR Measurement With Contrast-enhanced Dynamic MRI
External Ionizing Radiation to Prevent Restenosis on Haemodialysis Vascular Access
Total Laparoscopic Versus Open Aortic Surgery for Abdominal Aortic Disease
Prevention of Autogenous Vein Graft Failure in Peripheral Artery Bypass Procedures
A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in Preventing Post-Angioplasty Blood Vessel Re-Closure (Restenosis) in Stented Vessels.
Research Network
Common Treatments
- Bo6531
- External Ionizing Radiations1
- Contrastenhanced Dynamic Mri1
- Cgt003 E2f Duplex Decoy1
- Aortic Repair1
Active Sponsors
- University Hospital, Bordeaux2
- Anesiva, Inc.1
- University of Poitiers1
- Chugai Pharma USA1
- Ministry of Health, France1
Top Investigators
University Hospital, Bordeaux, France
University Hospital, Bordeaux, France
University Hospital, Bordeaux, France
Anesiva, Inc.
Related Conditions
- Transplantation Kidney1
- Intimal Hyperplasia1
- Peripheral Vascular Diseases1
- Arterial Occlusive Diseases1
- Ischemia1